GE

Sanofi to collaborate with the Center for Genomic Regulation

Friday, March 9, 2012 02:21 PM

The Center for Genomic Regulation (CRG), an international biomedical research institute of excellence supported by the Catalan government and the Spanish Ministry of Science and Innovation, has entered a research collaboration with Sanofi to share research programs using state-of-the-art experimental platforms and computational and bioinformatics approaches, in computational biology, medical genetics and epigenetics, with special emphasis in genetic and rare diseases.

More... »

GE Healthcare to acquire Xcellerex

Friday, March 9, 2012 02:10 PM

U.K.-based GE Healthcare, a unit of GE, will acquire Xcellerex, a supplier of manufacturing technologies for the biopharmaceutical industry.

More... »

AmerisourceBergen to acquire World Courier

Thursday, March 8, 2012 12:31 PM

AmerisourceBergen has agreed to purchase World Courier Group, a privately held global specialty transportation and logistics provider for the biopharmaceutical industry, for $520 million in cash.

More... »

Genticel completes recruitment for phase Ib HPV vaccine trial

Wednesday, March 7, 2012 06:15 AM

Genticel, a biopharmaceutical company based in Toulouse and Paris, France, has completed the recruitment of all patients participating in its phase Ib clinical trial evaluating a lyophilized formulation of ProCervix, its candidate therapeutic HPV vaccine, on adult women already infected with human papillomavirus (HPV) genotypes 16 or 18.

More... »

NinePoint Medical initiates trial of imaging system for esophagus

Tuesday, March 6, 2012 06:10 AM

NinePoint Medical, a developer of medical devices for in vivo pathology, has initiated a clinical trial to evaluate high-resolution optical imaging of Barrett’s esophagus using its proprietary Nvision VLE Imaging System, which received 510(k) clearance from the FDA earlier this year.

More... »

OncoGenex reports promising preclinical cancer data

Monday, March 5, 2012 06:09 AM

OncoGenex Pharmaceuticals’ compound OGX-427 shows potential for augmenting anti-cancer therapies and delay tumor progression.

More... »

Clinical Research Advantage adds clinical trials in rural Nebraska

Friday, March 2, 2012 01:39 PM

Tempe, Ariz.-based Clinical Research Advantage (CRA), a provider of research services to pharmaceutical companies and CROs, will begin offering patients throughout rural Nebraska the opportunity to participate in additional clinical trials.

More... »

The CenterWatch Monthly, March 2012

Thursday, March 1, 2012 06:05 AM

Living in a post-M&A world of CROs

More... »

PRECOS appoints Dr. Martin Page scientific consultant

Thursday, March 1, 2012 06:04 AM

Preclinical Oncology Services Limited (PRECOS), a preclinical R&D service provider with a focus on oncology, has appointed Dr. Martin Page scientific consultant.

More... »

Shire and arGEN-X enter therapeutic antibody alliance

Wednesday, February 29, 2012 04:12 PM

Netherlands-based arGEN-X has entered into an alliance with U.K.-based Shire Pharmaceuticals to create novel therapeutic antibody products against multiple targets submitted by the latter.

More... »